Maria Fardis's Net Worth
$7.34 Million
Who is Maria Fardis?
Maria Fardis has an estimated net worth of $7.34 Million. This is based on reported shares across multiple companies, which include Lion Biotechnologies, Inc., PHARMACYCLICS INC, and CRISPR Therapeutics AG.
SEC CIK
Maria Fardis's CIK is 0001559231
Past Insider Trading and Trends
2014 was Maria Fardis's most active year for acquiring shares with 7 total transactions. Maria Fardis's most active month to acquire stocks was the month of May. 2018 was Maria Fardis's most active year for disposing of shares, totalling 12 transactions. Maria Fardis's most active month to dispose stocks was the month of October. 2014 saw Maria Fardis paying a total of $119,080.49 for 55,205 shares, this is the most they've acquired in one year. In 2017 Maria Fardis cashed out on 207,131 shares for a total of $1,236,745.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lion Biotechnologies, Inc. (IOVA) Snapshot price: $10.25
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -0.63% | -1.89K |
$33.12 | -$62,729.28 | 298.79K |
Jun 1
| |||
Form 4
| -0.63% | -1.89K |
$32.00 | -$60,608.00 | 300.68K |
May 1
| |||
Form 4
| -0.49% | -1.49K |
$27.94 | -$41,742.36 | 302.57K |
Apr 1
| |||
Form 4
| -0.43% | -1.32K |
$35.99 | -$47,542.79 | 304.07K |
Mar 2
| |||
Form 4
| -0.42% | -1.30K |
$22.54 | -$29,347.08 | 305.39K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -0.51% | -1.56K |
$26.68 | -$41,674.16 | 306.69K |
Jan 2
| |||
Form 4
| -1.21% | -3.79K |
$22.32 | -$84,529.22 | 308.25K |
Nov 1 - Dec 2
| |||
Form 4
| -43.27% | -237.96K |
$7.08 | -$1,685,563.95 | 312.04K |
Apr 3 - Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
∞
| 550K |
—
|
—
| 550K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMACYCLICS INC No price found
Chief Oncology Ops & Allian
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$74.07 | -$403,381.80 | 3.19K |
Nov 13
| |||
Form 4
|
—
|
0
|
$70.67 | -$638,300.00 | 3.19K |
Nov 7
| |||
Form 4
| +0.03% | 1 |
$80.93 | $80.93 | 3.19K |
Oct 31
| |||
Form 4
|
—
|
0
|
$63.93 | -$456,680.00 | 3.19K |
Aug 13
| |||
Form 4
| +6.83% | 204 |
$80.39 | $16,399.56 | 3.19K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
$73.67 | -$400,983.60 | 2.99K |
Mar 5
| |||
Form 4
| +206.15% | 2.01K |
$10.56 | $21,240.68 | 2.99K |
Apr 30
| |||
Form 4
| -71.92% | -2.50K |
$65.00 | -$162,500.00 | 976 |
Jan 8
| |||
Form 4
|
—
|
0
|
$35.52 | -$200,760.00 | 3.48K |
Jan 7 - Jan 7
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +10.38% | 327 |
$10.56 | $3,452.14 | 3.48K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||